Synthesis of advanced functional materials and their applications
The Yu Group, led by Senior Group Leader Professor Chengzhong (Michael) Yu, has a research focus on the designed synthesis of advanced functional materials and their applications in drug delivery, bio-analysis, environmental protection and energy storage. Additionally, the Group has worked with a number of collaborative partners to explore commercial applications of their work through innovation in nanomaterials.
The Yu Group focusses their research across Agriculture nanotechnology and Advanced materials which are two of AIBN’s Five Pillars of Research.
Research Highlights
N4 Pharma
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need
Elanco
Elanco Animal Health is a global leader in the discovery and development of products that improve animal health, performance and well-being.
Anpario
Anpario offers products that work in harmony with the natural aspects of the animal’s biology to promote healthy growth.
Ellume
Ellume is a health technology company that commercialises quantum dot based diagnostics to enable real-time detection of common conditions, such as influenza, strep throat, and chlamydia.
News
-
-
Funding to boost life-changing research at AIBN
2 June 2020 -
Nano-implants to remove the pain of diabetes injections
16 February 2017 -
Biocompatible nanoparticles to fight bacterial infections
5 December 2016 -
AIBN star awarded by UQ
18 September 2014 -
Researchers step closer to targeting diseased cells
21 February 2014
